在急性中使用声遗传学调节GABAergic神经元
Thi-Nhan Phan1, Ching-Hsiang Fan2, Hsien-Chu Wang3
1Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 30013, Taiwan.
概括
这项研究介绍了音频遗传学作为一种非侵入性治疗方法. 工程神经元的超声波刺激在老鼠中抑制了50%的活动,提供了一种安全的新疗法方法.
科学领域:
- 神经科学是一个神经科学.
- 生物技术是生物技术.
- 医疗工程 医疗工程
背景情况:
- 治疗面临着当前的侵入性方法 (如手术和深度脑刺激) 的局限性.
- 现有的神经调节技术往往具有非目标效应和有限的精度.
- 对于治疗有需要的非侵入性,向性疗法.
研究的目的:
- 调查音频遗传学作为治疗的非侵入性方法.
- 用超声波选择性地刺激γ-氨基黄油酸 (GABA) 活性神经元.
- 评估在鼠模型中声遗传神经调节的疗效和安全性.
主要方法:
- 利用声遗传学与工程听觉感应蛋白 (mPrestin N7T,N308S) 来准GABAergic神经元.
- 给出0.5MHz的横超声波来激活杏仁体中的工程神经元.
- 采用氨基醇诱导的老鼠模型来模仿型活动.
- 进行了电生理学记录,以评估神经调节和抑制.
主要成果:
- 对GABAergic神经元的声遗传激活可调节型活动50%.
- 在治疗后长达60分钟的时间内实现了持续的发作抑制.
- 经证实有效的神经调节,没有可观察到的组织损伤,炎症或亡.
- 证明了非侵入性声基因方法的安全性和有效性.
结论:
- 音频遗传学为管理提供了一个有前途的非侵入性替代方案.
- 通过超声波准GABAergic神经元提供了精确而安全的神经调节.
- 这种方法在开发新疗法方面取得了重大进展.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
334
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
334
Antiepileptic Drugs: Glutamate Antagonists
284
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
284
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
253
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
253
Arteries of the Lower Limbs
178
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
178
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K


